Growth leadership Recent executive hires including a Chief Marketing Officer and Chief Global Growth Officer indicate a strategic push toward expanded market reach and physician-dispensed positioning. Sales teams can target hospital systems, dermatology clinics, and med-spa networks with collaborations, distribution partnerships, and co-marketing opportunities aligned to this growth trajectory.

Product pipeline New product launches and awards in 2025–2026, such as DEJ BioStim and the CMT Post-Procedure Cream, signal ongoing innovations in post-procedure skin health. Opportunities exist to upsell to clinics and retailers seeking clinically validated, dermatologist-endorsed regimens, and to bundle new products with existing professional services.

Clinical validation Emphasis on pharmaceutical-style clinical testing and NewBeauty Award wins underscore credibility with medical and consumer audiences. This can be leveraged to secure partnerships with medical-grade distributors, bargaining for exclusive SPA/clinic showcases, and entering prestige-focused retail channels.

Digital and tech leverage Adoption of Salesforce, Shopify, WordPress, and marketing automation tools suggests a modern, multi-channel go-to-market. Sales teams can propose integrated e-commerce, CRM-driven enrollment programs for clinics, and data-backed marketing collaborations to optimize co-branding and performance campaigns.

Market positioning Positioning as a physician-dispensed, long-term skin health brand with medical-grade credentials aligns with mid-to-high end dermatology and med-spa ecosystems. Potential sales opportunities include exclusive brand partnerships, private-label discussions, and targeted outreach to high-value clinics seeking durable, science-backed skincare offerings.